We showed that low CDX2 expression was significantly correlated with poor prognostic features including lack of tumour differentiation, presence of lymphovascular or perineural invasion and poorer OS and DFS outcomes in both colon and rectal cancers. The gene discussed is CDX2; the disease is neoplasm.